Assistant Professor, Psychiatry, University of Miami School of Medicine
Psychiatry
Dr. Martin T. Strassnig, MD
|
|
Give Review
Martin Strassnig works in the field of Psychiatry. Martin Strassnig is a published doctor as well. He has 39 publications published. The latest was: High velocity circuit resistance training improves cognition, psychiatric symptoms and neuromuscular performance in overweight outpatients with severe mental illness. Martin T. Strassnig, MD accepts Medicare.
Publications
- Absence of bias in clinician ratings of everyday functioning among African American, Hispanic and Caucasian patients with schizophrenia.
- High velocity circuit resistance training improves cognition, psychiatric symptoms and neuromuscular performance in overweight outpatients with severe Mental illness.
- Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity.
- Body composition, pre-diabetes and cardiovascular disease risk in early schizophrenia.
- Factors influencing self-assessment of cognition and functioning in schizophrenia: Implications for treatment studies.
- Treatment resistance and other complicating factors in the management of schizophrenia.
- Physical performance and disability in schizophrenia.
- Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar Disorder and schizophrenia.
- The course of vocational functioning in patients with schizophrenia: Re-examining social drift.
- Treatment of obesity and disability in schizophrenia.
- Diabetes resolution following discontinuation of a second-generation antipsychotic.
- Health-Related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary study.
- Exercise improves physical capacity in obese patients with schizophrenia: pilot study.
- Predicting the severity of everyday functional disability in people with schizophrenia: cognitive Deficits, functional capacity, symptoms, and health status.
- Risperidone plasma levels, clinical response and side-effects.
- How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?
- Electroconvulsive therapy in a patient with Tourette''s syndrome and co-morbid Obsessive Compulsive Disorder.
- COX-2 inhibitors as adjunctive therapy in schizophrenia.
- Nutritional assessment of patients with schizophrenia: a preliminary study.
- Body mass index and quality of life in community-dwelling patients with schizophrenia.
- Prevention of metabolic syndrome in serious Mental illness.
- Dietary intake of patients with schizophrenia.
- Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia.
- About a peculiar disease of the cerebral cortex: Alzheimer's original case revisited.
- Quetiapine in the treatment of schizophrenia and related Disorders.
- Predictive eye and hand movements are differentially affected by schizophrenia.
- Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
- Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.
- Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
- Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia.
- Are older antipsychotic Drugs obsolete?
- General medical and psychiatric perspectives on somatoform Disorders: separated by an uncommon language.
- Decreased T cellular immune response in schizophrenic patients.
- Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
- COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date.
- Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia.
- Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia.
- ICAM G241A polymorphism and soluble ICAM-1 serum levels: evidence for an active immune process in schizophrenia.
Procedures Preformed
- Electroconvulsive Therapy (ECT)
- Psychiatric Medication Therapy
Conditions Treated
- Adjustment Disorder
- Alcohol-Induced Mental Disorders
- Alcoholism (Alcohol Dependence)
- Antisocial Personality Disorder
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
University of Pittsburgh Medical Center -
Karl-Franzens University of Graz Faculty of Medicine
Drug Facts
| NPI NUMBER | 1083815344 | |
| NPPES Provider LastName | STRASSNIG | |
| NPPES Provider FirstName | MARTIN | |
| NPPES Provider ZIPCode | 331362107 | |
| NPPES Provider State | FL | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 95.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083815344 |
| Last Name Of The Provider | STRASSNIG |
| First Name Of The Provider | MARTIN |
| View All |
Similar Doctors
|
|
Dr. Joseph H. Henry, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles B. Nemeroff, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sandra P. Baquero, MD |
|
|
Dr. Elizabeth A. Crocco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesus E. Linares II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James H. Cook II, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Samuel E. Roura, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguel A. Chavez Jr., MD |
|
|
Dr. Francisco R. Audivert, MD |
|
|
Dr. Benjamin L. Egusquiza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Krystal L. Kleinberg, MD |
|
|
Dr. Ihsan M. Salloum, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|